205 related articles for article (PubMed ID: 22047792)
1. Regulation of murine cardiac function by phosphodiesterases type 3 and 4.
Beca S; Aschars-Sobbi R; Panama BK; Backx PH
Curr Opin Pharmacol; 2011 Dec; 11(6):714-9. PubMed ID: 22047792
[TBL] [Abstract][Full Text] [Related]
2. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
3. Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model.
Mika D; Bobin P; Lindner M; Boet A; Hodzic A; Lefebvre F; Lechène P; Sadoune M; Samuel JL; Algalarrondo V; Rucker-Martin C; Lambert V; Fischmeister R; Vandecasteele G; Leroy J
J Mol Cell Cardiol; 2019 Aug; 133():57-66. PubMed ID: 31158360
[TBL] [Abstract][Full Text] [Related]
4. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
Osadchii OE
Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
[TBL] [Abstract][Full Text] [Related]
6. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes.
Kerfant BG; Zhao D; Lorenzen-Schmidt I; Wilson LS; Cai S; Chen SR; Maurice DH; Backx PH
Circ Res; 2007 Aug; 101(4):400-8. PubMed ID: 17615371
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
8. [Role of cyclic nucleotide phosphodiesterases type 3 and 4 in cardiac excitation-contraction coupling and arrhythmias].
Mika D; Leroy J; Fischmeister R; Vandecasteele G
Med Sci (Paris); 2013; 29(6-7):617-22. PubMed ID: 23859516
[TBL] [Abstract][Full Text] [Related]
9. [Role of cyclic nucleotide phosphodiesterases in the cAMP compartmentation in cardiac cells].
Mika D; Leroy J; Vandecasteele G; Fischmeister R
Biol Aujourdhui; 2012; 206(1):11-24. PubMed ID: 22463992
[TBL] [Abstract][Full Text] [Related]
10. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
Kokkonen K; Kass DA
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
[TBL] [Abstract][Full Text] [Related]
12. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
13. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
15. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
[TBL] [Abstract][Full Text] [Related]
16. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
Stangherlin A; Zaccolo M
Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
[TBL] [Abstract][Full Text] [Related]
17. [Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].
Bedioune I; Bobin P; Karam S; Lindner M; Mika D; Lechêne P; Leroy J; Fischmeister R; Vandecasteele G
Biol Aujourdhui; 2016; 210(3):127-138. PubMed ID: 27813474
[TBL] [Abstract][Full Text] [Related]
18. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
Johnson WB; Katugampola S; Able S; Napier C; Harding SE
Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of phosphodiesterase inhibition in intact cells.
Herget S; Lohse MJ; Nikolaev VO
Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.
Abi-Gerges A; Richter W; Lefebvre F; Mateo P; Varin A; Heymes C; Samuel JL; Lugnier C; Conti M; Fischmeister R; Vandecasteele G
Circ Res; 2009 Oct; 105(8):784-92. PubMed ID: 19745166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
